When.com Web Search

  1. Ads

    related to: full genome sequencing companies pros and cons

Search results

  1. Results From The WOW.Com Content Network
  2. Nebula Genomics - Wikipedia

    en.wikipedia.org/wiki/Nebula_Genomics

    BGI Group is a Chinese life sciences company that has been part of many controversies, especially regarding genetic data. One of these concerns one of the most popular prenatal test in the world, Reuters found out that it has been developed with the involvement of Chinese's army, People's Liberation Army (PLA), and has been used to collect genetic data from millions of women.

  3. Whole genome sequencing - Wikipedia

    en.wikipedia.org/wiki/Whole_genome_sequencing

    Because of this, full genome sequencing is considered a disruptive innovation to the DNA array markets as the accuracy of both range from 99.98% to 99.999% (in non-repetitive DNA regions) and their consumables cost of $5000 per 6 billion base pairs is competitive (for some applications) with DNA arrays ($500 per 1 million basepairs). [42]

  4. MGI (company) - Wikipedia

    en.wikipedia.org/wiki/MGI_(company)

    In March 2013, Complete Genomics was acquired by BGI Group. [17] After the acquisition, Complete Genomics moved to San Jose, and in June 2018 became part of MGI. [18] [19] The acquisition was the one of the outcomes of $1.5 billion 'collaborative funds' i.e., '10 years loan' which was initially provided by China Development Bank to acquire all 128 of Illumina, Inc.'s newest and fastest next ...

  5. Shotgun sequencing - Wikipedia

    en.wikipedia.org/wiki/Shotgun_sequencing

    The process of extensive BAC library creation and tiling path selection, however, make hierarchical shotgun sequencing slow and labor-intensive. Now that the technology is available and the reliability of the data demonstrated, [14] the speed and cost efficiency of whole-genome shotgun sequencing has made it the primary method for genome ...

  6. Veritas Genetics - Wikipedia

    en.wikipedia.org/wiki/Veritas_Genetics

    In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their inherited genetic risk including cancer, cardiovascular and carrier status, reaction to certain medications (pharmacogenomics) and more, all based on whole-genome sequencing results. The company further reduced ...

  7. Personal genomics - Wikipedia

    en.wikipedia.org/wiki/Personal_genomics

    Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips (typically 0.02% of the genome), or partial or full genome sequencing.

  1. Ad

    related to: full genome sequencing companies pros and cons